Literature DB >> 9192508

Bone mineral density in patients with human immunodeficiency virus infection.

N I Paton1, D C Macallan, G E Griffin, M Pazianas.   

Abstract

The Object of this study was to determine whether HIV infection is associated with decreased bone mineral density (BMD). BMD was measured by dual-energy X-ray absorptiometry at total body, lumbar spine, and hip in 45 men with HIV infection and compared with sex, age, and weight-matched controls. Repeat scans were performed after a mean interval of 15 months in 21 patients to determine whether there were detectable losses of BMD. Compared with controls, the HIV patients had marginally lower BMD at the lumbar spine (P = 0.04) but there was no significant difference in total body or hip BMD. None of the patients had reduced BMD to levels associated with a diagnosis of osteoporosis. On longitudinal follow-up, a small decrease in total body BMD (-1.6%; P = 0.02) was observed but there was no significant change in spine and hip BMD. In spite of the many features of HIV infection that might be expected to cause a reduction in BMD such as cytokine activation, decreased physical activity, small bowel disease, hypogonadism, and direct infection of osteogenic cells by HIV, we found only minimal differences in BMD between HIV patients and controls. Furthermore, the HIV patients studied did not appear to show excessive loss in bone mineral over time.

Entities:  

Mesh:

Year:  1997        PMID: 9192508     DOI: 10.1007/s002239900288

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  20 in total

1.  Bone mass and mineral metabolism in HIV+ postmenopausal women.

Authors:  Michael Yin; Jay Dobkin; Karen Brudney; Carolyn Becker; Janis L Zadel; Monica Manandhar; Vicki Addesso; Elizabeth Shane
Journal:  Osteoporos Int       Date:  2005-03-08       Impact factor: 4.507

2.  Longitudinal analysis of bone density in human immunodeficiency virus-infected women.

Authors:  Sara E Dolan; Jenna R Kanter; Steven Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2006-05-30       Impact factor: 5.958

3.  Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy.

Authors:  P Tebas; W G Powderly; S Claxton; D Marin; W Tantisiriwat; S L Teitelbaum; K E Yarasheski
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

4.  Reduced Serum Osteocalcin in High-Risk Alcohol Using People Living With HIV Does Not Correlate With Systemic Oxidative Stress or Inflammation: Data From the New Orleans Alcohol Use in HIV Study.

Authors:  James Watt; Jonathan Schuon; Jacob Davis; Tekeda F Ferguson; David A Welsh; Patricia E Molina; Martin J J Ronis
Journal:  Alcohol Clin Exp Res       Date:  2019-10-01       Impact factor: 3.455

Review 5.  Pathogenesis of osteopenia/osteoporosis induced by highly active anti-retroviral therapy for AIDS.

Authors:  George Pan; Zhen Yang; Scott W Ballinger; Jay M McDonald
Journal:  Ann N Y Acad Sci       Date:  2006-04       Impact factor: 5.691

6.  Modulation of osteoclastogenesis induced by nucleoside reverse transcriptase inhibitors.

Authors:  George Pan; Michael Kilby; Jay M McDonald
Journal:  AIDS Res Hum Retroviruses       Date:  2006-11       Impact factor: 2.205

7.  The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling.

Authors:  Michael W-H Wang; Shi Wei; Roberta Faccio; Sunao Takeshita; Pablo Tebas; William G Powderly; Steven L Teitelbaum; F Patrick Ross
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

8.  Mapping the prescriptiome to fractures in men--a national analysis of prescription history and fracture risk.

Authors:  B Abrahamsen; K Brixen
Journal:  Osteoporos Int       Date:  2008-08-09       Impact factor: 4.507

Review 9.  Adverse effects of antiretroviral therapy for HIV infection.

Authors:  Valentina Montessori; Natasha Press; Marianne Harris; Linda Akagi; Julio S G Montaner
Journal:  CMAJ       Date:  2004-01-20       Impact factor: 8.262

10.  Risk factors for decreased bone density and effects of HIV on bone in the elderly.

Authors:  S Jones; D Restrepo; A Kasowitz; D Korenstein; S Wallenstein; A Schneider; M J Keller
Journal:  Osteoporos Int       Date:  2007-12-11       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.